ISIS PHARMACEUTICALS INC

Company

IONIS PHARMACEUTICALS INC

Filed

February 6, 2013

Accession Number

0001193125-13-040029

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →